Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Tamasauskiene (Kaunas, Lithuania), V. Gintauskiene (Kaunas, Lithuania), E. Gasiuniene (Kaunas, Lithuania), B. Sitkauskiene (Kaunas, Lithuania). Late Breaking Abstract - Link between IL-22 and IL-10, IL-13, and severity of symptoms in patients with allergic airway diseases caused by house dust mite. 307

Member's Comments

No comment yet.

Related content which might interest you: Oral presentation: Early sources of IL-13 in house dust mite-induced neonatal allergic airways disease Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013 LSC 2013 abstract - Early sources of IL-13 in house dust mite-induced neonatal allergic airways disease Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 House dust mite induces direct airway inflammation in vivo: implications for future disease therapy? Source: Eur Respir J 2010; 35: 1377-1387 Year: 2010 YS2: Role of Th9 cells in allergic airway inflammation induced by house dust mite Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease Year: 2011 Antisense-ECE RNA inhibited dust mite-induced IL-5 release from PBMCs of patients with allergic asthma Source: Eur Respir J 2003; 22: Suppl. 45, 546s Year: 2003 Expression of nasal and bronchial IL-17F and related cytokines in frequent exacerbators with neutrophilic severe asthma Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Young Investigator session: Inhibition of airway hyperresponsiveness and inflammation by vaccination against IL-33 in a house dust mite model of asthma Source: Lung Science Conference 2014 - Lung Inflammation and Immunity Year: 2014 Farm dust decreases Th2 driven allergic airway inflammation in mice: A role for airway TLR2 and TLR4? Source: Annual Congress 2011 - T-cell subsets Year: 2011 Inflammatory markers in induced sputum of patients with allergic rhinitis in relation to exposure to pollen allergens Source: Eur Respir J 2006; 28: Suppl. 50, 444s Year: 2006 IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: a marker of Th-2 phenotype status? Source: International Congress 2017 – Monitoring asthma control Year: 2017 Late-breaking abstract: House dust mite triggering of Dectin-2 is critical for the initiation of allergic airway inflammation Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New mechanisms in airway disease Year: 2011 Pigeon fanciers’ allergic alveolitis: association with pro-inflammatory cytokines Source: Eur Respir J 2004; 24: Suppl. 48, 355s Year: 2004 Association between Th2 biomarker levels and efficacy of house dust mite sublingual allergy immunotherapy in adults with allergic asthma Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 Pathology, inflammation and cytokines of severe asthma Source: Eur Respir Mon 2011; 51: 97-106 Year: 2011 Late Breaking Abstract - Systemic IL-26 correlates with improved asthma control in children with allergic sensitization Source: International Congress 2018 – Molecular and cellular determinants of the developing lung Year: 2018 Local and systemic inflammatory responses following bronchial instillation of house dust mite allergen (HDM) and HDM/lipopolysaccharide (LPS) in mild asthmatics Source: Annual Congress 2011 - Mechanisms of allergic inflammation of the airways Year: 2011 Circulating platelets activity in patients sensitised to house dust mite suffering from persistent allergic rhinitis with or without asthma symptoms Source: Eur Respir J 2005; 26: Suppl. 49, 590s Year: 2005 Induced sputum levels of soluble receptor ST-2 in adult patients suffering from allergic asthma or allergic rhinitis Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Levels of house dust mites (HDM) in homes of patients with bronchial asthma (BA) and the airway inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 281s Year: 2001 Chemokine and cytokine production in the airway from atopic asthmatics after segmental allergen challenge Source: Eur Respir J 2003; 22: Suppl. 45, 378s Year: 2003